Suppliers / Matrix Pharmacorp

Matrix Pharmacorp

India 646 employees Updated 9 July 2026

Matrix Pharmacorp is an API manufacturer based in India. It holds 223 active US drug master files. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 28 November 2025 as VAI. Customs aggregates show $7.4M of exports covering 51 molecules to 16 destinations in 2025.

223
active US DMFs
0
valid CEPs
5
registered plants 5 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
5 of 5 confirmed
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 28 November 2025 VAI US FDA
  • 7 November 2025 VAI US FDA
  • 5 September 2025 VAI US FDA
  • 5 May 2023 NAI US FDA
  • 17 September 2022 VAI US FDA
  • 23 November 2019 VAI US FDA
  • 5 June 2019 OAI US FDA
  • 8 February 2019 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Visakhapatnam, India 3009590042
Hyderabad, India 3004713397
Vizianagaram, India 3002785310
Hyderabad, India 3003227156
Visakhapatnam, India 3008861594

What they file, and where

Molecule Regulators Docs
Darunavir US FDA 3
Efavirenz US FDA 3
Emtricitabine US FDA 3
Esomeprazole US FDA 3
Paliperidone US FDA 3
Tenofovir Disoproxil US FDA 3
Alprazolam US FDA 2
Aripiprazole US FDA 2
Atazanavir US FDA 2
Cabotegravir US FDA 2
Show all 30 molecules on file
Canagliflozin US FDA 2
Carvedilol US FDA 2
Dolutegravir US FDA 2
Eletriptan US FDA 2
Elvitegravir US FDA 2
Epinephrine US FDA 2
Felbamate US FDA 2
Iron Sucrose US FDA 2
Lamivudine US FDA 2
Lanthanum Carbonate US FDA 2
Mafenide US FDA 2
Nepafenac US FDA 2
Phentolamine US FDA 2
Pomalidomide US FDA 2
Raltegravir US FDA 2
Sertraline US FDA 2
Stavudine US FDA 2
Sugammadex US FDA 2
Tetrabenazine US FDA 2
Valganciclovir US FDA 2

Also appears on these molecule pages

Show 119 more molecule pages
Avatrombopag API Azathioprine API Baclofen API Bictegravir API Bosentan API Cabotegravir API Canagliflozin API Candesartan API Carvedilol API Cetirizine API Cevimeline API Chlorthalidone API Citalopram API Clofarabine API Clozapine API Cobicistat API Dacarbazine API Darunavir API Deferasirox API Desloratadine API Dexlansoprazole API Dipyridamole API Dofetilide API Dolutegravir API Droxidopa API Efavirenz API Efinaconazole API Eletriptan API Elvitegravir API Emtricitabine API Epinephrine API Eszopiclone API Ezetimibe API Febuxostat API Felbamate API Ferric Carboxymaltose API Fexofenadine API Fingolimod API Fluconazole API Flucytosine API Formoterol API Gabapentin API Gatifloxacin API Icatibant API Itraconazole API Lamivudine API Lamotrigine API Lansoprazole API Lanthanum Carbonate API Lenalidomide API Leuprolide API Lopinavir API Loratadine API Macitentan API Memantine API Miglustat API Milnacipran API Mirtazapine API Modafinil API Montelukast API Nabumetone API Nadolol API Nepafenac API Nevirapine API Octreotide API Oseltamivir API Palbociclib API Paliperidone API Paroxetine API Pentosan Polysulfate API Phentolamine API Pioglitazone API Pitavastatin API Plecanatide API Plerixafor API Pomalidomide API Prasugrel API Proguanil API Pyrazinamide API Raltegravir API Rasagiline API Regadenoson API Rilpivirine API Risedronic Acid API Risperidone API Ritonavir API Rivastigmine API Rizatriptan API Roflumilast API Rotigotine API Sacubitril/Valsartan API Saxagliptin API Selegiline API Sertraline API Sevelamer API Sildenafil API Sofosbuvir API Sumatriptan API Tenofovir Alafenamide API Tenofovir Disoproxil API Tetrabenazine API Tizanidine API Tofacitinib API Trazodone API Valaciclovir API Valacyclovir API Valganciclovir API Varenicline API Verapamil API Vilazodone API Voriconazole API Vortioxetine API Zidovudine API Zileuton API Zolmitriptan API Zolpidem API Esomeprazole API Aripiprazole API Sugammadex API

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA None 3

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $14.0M 29
2025 Not reported $7.4M 16

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Matrix Pharmacorp

Does Matrix Pharmacorp hold a US DMF or a CEP?
Matrix Pharmacorp holds 223 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Matrix Pharmacorp FDA-registered?
5 sites operated by Matrix Pharmacorp carry an FDA establishment identifier (FEI), which means they are registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Matrix Pharmacorp's last inspection go?
The most recent inspection on record closed on 28 November 2025 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 8 inspections are on file, of which 1 closed as OAI.
Where does Matrix Pharmacorp manufacture?
5 registered sites are on record, in India (Visakhapatnam, Hyderabad and Vizianagaram among others). Every site is listed on this page with the register it came from.
What does Matrix Pharmacorp make?
30 molecules are on record against Matrix Pharmacorp, including Darunavir, Efavirenz, Emtricitabine and Esomeprazole. Each links through to that molecule's full manufacturer list.
Which regulators recognise Matrix Pharmacorp's GMP?
Current GMP certificates are on record from US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Matrix Pharmacorp comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 28 November 2025.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts